FDA Inspection 1279897 — Akron Pharma, Inc.
The FDA completed an inspection of Akron Pharma, Inc. on August 12, 2025 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 12, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Fairfield, NJ (United States)
Additional Details
FSVP